gynecology-2018-scientifictracks

13 / 25

Page 55
Notes:
conferenceseries.com
Volume 8 Gynecology & Obstetrics
ISSN: 2161-0932 Gynecology 2018
October 08-10, 2018
October 08-10, 2018 | Zurich, Switzerland
5th International Conference on
Gynecology and Obstetrics
Determinants of survival of cervical cancer: A hospital based study
Rita Rani
Mahavir Cancer Sansthan and Research Centre, India
Globally uterine cervix cancer is one of the leading causes of death in females due to cancer, especially in developing
countries. The aim of the study was to analyse the survival as well as understanding various prognostic factors for survival
in patients of carcinoma cervix presenting in our hospital. A total of 508 patients were evaluated in radiotherapy department of
Mahavir Cancer Sansthan and Research Centre Patna, Bihar who came for follow up between April 2015 to March 2016 after
completion of radical radiotherapy. Out of 508 patients 3.54% (n 18), 71.65% (n 364), 22.83% (n 116) and 1.9% (n 10) patients
presented in stage I, II, III and IV A respectively. 53.54% of patients belonged to age group of 35 to 50 years with survival
of 937±53.49 days. 46.46% of the patients were more than 50 years age and their survival was 933.3±57.12 days. The mean
duration for overall survival for all cases evaluated was 957.4±39.49 days. The mean duration for survival of stages I, II, III
and IVA was 1186±281.8 days, 960±85.04 days, 945.1±45.66 days and 765±181.5 days respectively. Survival of patients having
squamous cell carcinoma was 970±42.89 days and that of adenocarcinoma was 669.5±120 days and that of premenopausal
and postmenopausal lady was 997.5±79.28 and 940.1±45.39 days respectively. It was evident from study that patients who
presented in early stage had a better survival. There was no significant difference in survival of cervix cancer patients in
different age groups while survival was greater in premenopausal cervical cancer patients.
Biography
Rita Rani has completed her Medical Graduation followed by Post-Graduation in Radiation Oncology. She is a Senior Consultant in Radiation Oncology at Mahavir Cancer
Sansthan and Research Institute, Patna, India. She has special interest in Gynecologic Oncology and has extensive experience of more than 10 years in this field. She has
more than 10 publications in reputed journals. Currently, she is Centre Principal Investigator at National Centre for Disease Informatics and Research, India.
Rita Rani, Gynecol Obstet 2018, Volume 8
DOI: 10.4172/2161-0932-C4-033